MedX Health Corp (MDX.V)
| Previous Close | 0.1200 |
| Open | 0.1150 |
| Bid | 0.1100 x 0 |
| Ask | 0.1150 x 0 |
| Day's Range | 0.1100 - 0.1150 |
| 52 Week Range | 0.1000 - 0.2600 |
| Volume | 263,500 |
| Avg. Volume | 167,079 |
| Market Cap | 20.92M |
| Beta (5Y Monthly) | -0.05 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0230 |
| Earnings Date | Nov. 29, 2021 - Dec. 03, 2021 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Newsfile
MedX to Present at Benzinga Healthcare Conference on September 30th
Mississauga, Ontario--(Newsfile Corp. - September 29, 2021) - MedX Health Corp. (TSXV: MDX) ("MedX" or the "Company"), a global leader in teledermatology, is pleased to announce its participation in the Benzinga Healthcare Small Cap Conference (the "Conference"), taking place virtually on Thursday, September 30th at 4:40 PM ET. MedX President & CEO, Sylvain Desjeans, along with Mike Druhan, President Dermatological Services, will present the Company's vision for scaling access to its unique derm
- Business Wire
MedX Health Corp. and Vitamed Biomedical s.r.l. to Pilot Leading-Edge Teledermatology Screening Platform in Italy
MISSISSAUGA, Ontario, September 27, 2021--MedX Health Corp. ("MedX" or the "Company") (MDX - TSXV) and Vitamed Biomedical s.r.l. ("Vitamed") are pleased to announce a Memorandum of Understanding between the companies to pilot MedX’s leading-edge DermSecure® Screening Platform at select pharmacies and general practitioner (GP) clinics in Italy this October.
- GlobeNewswire
Life Sciences Companies Investor Presentations Now Available for On-Demand Viewing
Individual and institutional investors as well as advisors are invited to log-on to LifeSciencesInvestorForum.com to view presentationsNEW YORK, Sept. 20, 2021 (GLOBE NEWSWIRE) -- Life Sciences Investor Forum today announced that the presentations from the September 16th conference are now available for on-demand viewing at LifeSciencesInvestorForum.com. This virtual event showcased live executive presentations and interactive discussions focused on publicly traded companies in the life sciences
